PDS Biotechnology PDSB
NASDAQ PDSB
$0.73 -0.02 (-3.17%)
As of: Oct 1, 2026 · 2:43 PM EDT

PDS Biotechnology (PDSB) Other Non-Current Liabilities (2014 - 2018)

Updated

PDS Biotechnology's Other Non-Current Liabilities was $291,225 in Q4 2018.

Analysis

PDS Biotechnology (PDSB) Other Non-Current Liabilities (2014 - 2018) Analysis & Trends

  • Other Non-Current Liabilities shows a four-year compound annual growth rate of -35.4% (FY2014 to FY2018).
  • In earlier years, Other Non-Current Liabilities was $1.67 million in FY2014.
  • The Q4 2018 figure marks the highest quarterly Other Non-Current Liabilities since Q3 2015.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 PDS Biotechnology 41.94 Mn 41.94 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2018 291,225.00
Sep 30, 2015 3.73 Mn
Dec 31, 2014 1.67 Mn
API Access

PDS Biotechnology Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=PDSB&period=max&api_key=YOUR_API_KEY